Pan Xu1, Xiubing Zhang2, Wenkai Ni3, Hui Fan2, Jian Xu2, Yongmei Chen2, Jia Zhu4, Xiaoling Gu4, Linlin Yang4, Runzhou Ni3, Buyou Chen5, Weidong Shi6. 1. Department of Radiotherapy, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong, 226001, Jiangsu Province, People's Republic of China. 2. Department of Medical Oncology, the Second Peoples Hospital of Nan Tong, 43 Tangzha Xinglong Road, Nantong, 226002, Jiangsu Province, People's Republic of China. 3. Department of Gastroenterology, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong, 226001, Jiangsu Province, People's Republic of China. 4. Department of Pathogen Biology, Jiangsu Province Key Laboratory for Information and Molecular Drug Target, Nantong University, 9 Qiangyuan Road, Nantong, 226019, Jiangsu Province, People's Republic of China. 5. Department of Radiotherapy, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong, 226001, Jiangsu Province, People's Republic of China. chenby1954chen@163.com. 6. Department of Medical Oncology, the Second Peoples Hospital of Nan Tong, 43 Tangzha Xinglong Road, Nantong, 226002, Jiangsu Province, People's Republic of China. shiweidong2015@163.com.
Abstract
BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. It is indispensable to understanding molecular mechanisms of HCC progression and to developing clinically useful biomarkers for this disease. AIM: In this article, we examined whether HOXC8 was associated with the poor prognosis of hepatocellular carcinoma and explored the possible underlying mechanism. METHODS: The HOXC8 and Ki67 expression levels in 86 patients with hepatocellular carcinoma were examined using immunohistochemistry. HOXC8 levels in HCC cells were downregulated by siRNA transfection. The cycle progression and cell proliferation status of HCC cells and the oxaliplatin effectiveness were evaluated by flow cytometry and CCK-8 assay. HOXC8, CyclinD1, PCNA, Nkd2, and cleaved caspase-3 levels were detected by western blot. RESULTS: HOXC8 was upregulated in HCC tissues, compared with adjacent non-tumor ones. HOXC8 expression levels in 86 patients with hepatocellular carcinoma were positively correlated with histological grade. Univariate and multivariate survival analysis revealed that HOXC8 was a significant predictor for overall survival of HCC patients. HOXC8 siRNA knockdown delayed the G1-S phase transition, inhibited cell proliferation, and attenuated resistance to oxaliplatin. CONCLUSIONS: HOXC8 promoted HCC proliferation and predicted poor prognosis. Furthermore, upregulated HOXC8 expression was associated with oxaliplatin resistance in hepatocellular carcinoma.
BACKGROUND:Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. It is indispensable to understanding molecular mechanisms of HCC progression and to developing clinically useful biomarkers for this disease. AIM: In this article, we examined whether HOXC8 was associated with the poor prognosis of hepatocellular carcinoma and explored the possible underlying mechanism. METHODS: The HOXC8 and Ki67 expression levels in 86 patients with hepatocellular carcinoma were examined using immunohistochemistry. HOXC8 levels in HCC cells were downregulated by siRNA transfection. The cycle progression and cell proliferation status of HCC cells and the oxaliplatin effectiveness were evaluated by flow cytometry and CCK-8 assay. HOXC8, CyclinD1, PCNA, Nkd2, and cleaved caspase-3 levels were detected by western blot. RESULTS:HOXC8 was upregulated in HCC tissues, compared with adjacent non-tumor ones. HOXC8 expression levels in 86 patients with hepatocellular carcinoma were positively correlated with histological grade. Univariate and multivariate survival analysis revealed that HOXC8 was a significant predictor for overall survival of HCC patients. HOXC8 siRNA knockdown delayed the G1-S phase transition, inhibited cell proliferation, and attenuated resistance to oxaliplatin. CONCLUSIONS:HOXC8 promoted HCC proliferation and predicted poor prognosis. Furthermore, upregulated HOXC8 expression was associated with oxaliplatin resistance in hepatocellular carcinoma.
Authors: C Wan; S Hou; R Ni; L Lv; Z Ding; X Huang; Q Hang; S He; Y Wang; C Cheng; X X Gu; G Xu; A Shen Journal: Oncogene Date: 2013-12-16 Impact factor: 9.867
Authors: R Calvo; J West; W Franklin; P Erickson; L Bemis; E Li; B Helfrich; P Bunn; J Roche; E Brambilla; R Rosell; R M Gemmill; H A Drabkin Journal: Proc Natl Acad Sci U S A Date: 2000-11-07 Impact factor: 11.205
Authors: Gary J Miller; Heidi L Miller; Adrie van Bokhoven; James R Lambert; Priya N Werahera; Osvaldo Schirripa; M Scott Lucia; Steven K Nordeen Journal: Cancer Res Date: 2003-09-15 Impact factor: 12.701
Authors: M K Sibin; S M Harshitha; K V L Narasingarao; I Bhat Dhananjaya; P Shukla Dhaval; G K Chetan Journal: J Mol Neurosci Date: 2016-10-28 Impact factor: 3.444